Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Phase 1 Study of Alvocidib (DSP-2033) in Combination with Cytarabine/Mitoxantrone (ACM) or Cytarabine/Daunorubicin (A+7+3) in Japanese Patients (Pts) with Acute Myeloid Leukemia (AML)

Yasuyoshi Morita, Takayuki Ikezoe, MD PhD, Kiyoshi Ando, Masahiro Onozawa, Takahisa Yamane, MD PhD, Naoko Hosono, MD PhD, Toru Kiguchi, Hiromi Iwasaki, Toshihiro Miyamoto, MD PhD, Miho Kasai, Saori Sugimoto, Yasushi Miyazaki, MD PhD, Masahiro Kizaki, MD, Koichi Akashi, MD PhD

Blood (2020) 136 (Supplement 1): 34–35.

https://doi.org/10.1182/blood-2020-134078

Published: 2020

Journal Articles

ASXL1 Mutations Predict a Poor Response to Darbepoetin Alfa in Anemic Patients with Low-Risk MDS: A Multicenter, Phase II Study

Hitoshi Hanamoto, Yasuyoshi Morita, Motoshi Ichikawa, Yasuhito Nannya, MD PhD, Hirohiko Shibayama, MD PhD, Yoshinobu Maeda, MD, Tomoko Hata, Toshihiro Miyamoto, MD PhD, Hiroshi Kawabata, MD PhD, Kazuto Takeuchi, Hiroko Tanaka, Junji Kishimoto, Satoru Miyano, PhD, Itaru Matsumura, MDPhD, Seishi Ogawa, MD PhD, Koichi Akashi, MD PhD, Yuzuru Kanakura, MD PhD, Kinuko Mitani

Blood (2020) 136 (Supplement 1): 28–29.

https://doi.org/10.1182/blood-2020-134483

Published: 2020

Journal Articles

Identification of a Patients-Derived CD34+ Myeloma Cell Population with Tumor-Propagating Capacity and Resistance to Anticancer Drugs

Kentaro Serizawa, Hirokazu Tanaka, MD PhD, Ayano Fukui, MD, Ryosuke Fujiwara, MD, Keigo Sano, MD, Hiroaki Inoue, MD, Takahiro Kumode, MD, Yasuhiro Taniguchi, MD, Yasuyoshi Morita, MD, Luis Espinoza, MDPhD, Itaru Matsumura, MDPhD

Blood (2017) 130 (Supplement 1): 1774.

https://doi.org/10.1182/blood.V130.Suppl_1.1774.1774

Published: 2017

Journal Articles

Management Of Pregnancy In Paroxysmal Nocturnal Hemoglobinuria (PNH): A Report Of 10 Cases From The Working Group On Pregnancy Of The Japan PNH Study Group

Kensuke Usuki, MD PhD, Akio Urabe, MD, PhD, Tatsuya Kawaguchi, MD, PhD, Naoyuki Miyasaka, MD, PhD, Osamu Miura, MD, PhD, Eriko Morishita, MD, PhD, Nobuyoshi Arima, MD, PhD, Yasuyoshi Morita, MD, PhD, Kaichi Nishiwaki, MD, Haruhiko Ninomiya, MD, PhD, Akihiko Gotoh, MD, PhD, Shinsaku Imashuku, MD, Tsutomu Shichishima, MD, PhD, Jun-ichi Nishimura, MD, PhD, Yuzuru Kanakura

Blood (2013) 122 (21): 2480.

https://doi.org/10.1182/blood.V122.21.2480.2480

Published: 2013

Journal Articles

Dichotomy of All- Trans Retinoic Acid Inducing Signals for Adult T-Cell Leukemia.

Yasuhiro Maeda, MD, PhD, Terufumi Yamaguchi, MD, PhD, Yasuki Hijikata, MD, Yasuyoshi Morita, MD, PhD, Chikara Hirase, MD, Syunsuke Takai, MD, Jun-ichi Miyatake, MD, PhD, Mitsuhiro Matsuda, MD, PhD, Akihisa Kanamaru, MD, PhD

Blood (2005) 106 (11): 4803.

https://doi.org/10.1182/blood.V106.11.4803.4803

Published: 2005

Journal Articles

Possible Eradication of Minimal Residual Disease in Acute Leukemia.

Yasuki Hijikata, MD, Yasuhiro Maeda, MD, PhD, Terufumi Yamaguchi, MD, Miyako Tanaka, MD, Chikara Hirase, MD, Takai Shunsuke, MD, Yasuyoshi Morita, MD, PhD, Mitsuhiro Matsuda, MD, PhD, Akihisa Kanamaru, MD, PhD

Blood (2005) 106 (11): 4599.

https://doi.org/10.1182/blood.V106.11.4599.4599

Published: 2005

NARROW

Phase 1 Study of Alvocidib (DSP-2033) in Combination with Cytarabine/Mitoxantrone (ACM) or Cytarabine/Daunorubicin (A+7+3) in Japanese Patients (Pts) with Acute Myeloid Leukemia (AML)

ASXL1 Mutations Predict a Poor Response to Darbepoetin Alfa in Anemic Patients with Low-Risk MDS: A Multicenter, Phase II Study

Identification of a Patients-Derived CD34+ Myeloma Cell Population with Tumor-Propagating Capacity and Resistance to Anticancer Drugs

Management Of Pregnancy In Paroxysmal Nocturnal Hemoglobinuria (PNH): A Report Of 10 Cases From The Working Group On Pregnancy Of The Japan PNH Study Group

Dichotomy of All- Trans Retinoic Acid Inducing Signals for Adult T-Cell Leukemia.

Possible Eradication of Minimal Residual Disease in Acute Leukemia.

Email alerts

ASH Publications

American Society of Hematology

Phase 1 Study of Alvocidib (DSP-2033) in Combination with Cytarabine/Mitoxantrone (ACM) or Cytarabine/Daunorubicin (A+7+3) in Japanese Patients (Pts) with Acute Myeloid Leukemia (AML)

ASXL1 Mutations Predict a Poor Response to Darbepoetin Alfa in Anemic Patients with Low-Risk MDS: A Multicenter, Phase II Study

Identification of a Patients-Derived CD34+ Myeloma Cell Population with Tumor-Propagating Capacity and Resistance to Anticancer Drugs

Management Of Pregnancy In Paroxysmal Nocturnal Hemoglobinuria (PNH): A Report Of 10 Cases From The Working Group On Pregnancy Of The Japan PNH Study Group

Dichotomy of All- Trans Retinoic Acid Inducing Signals for Adult T-Cell Leukemia.

Possible Eradication of Minimal Residual Disease in Acute Leukemia.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only